APA (7th ed.) Citation

Zhang, Z., Ma, Y., Guo, X., Du, Y., Zhu, Q., Wang, X., & Duan, C. (2021). FDX1 can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma. Frontiers in pharmacology, 12, 749134. https://doi.org/10.3389/fphar.2021.749134

Chicago Style (17th ed.) Citation

Zhang, Zeyu, Yarui Ma, Xiaolei Guo, Yingxi Du, Qing Zhu, Xiaobing Wang, and Changzhu Duan. "FDX1 Can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma." Frontiers in Pharmacology 12 (2021): 749134. https://doi.org/10.3389/fphar.2021.749134.

MLA (9th ed.) Citation

Zhang, Zeyu, et al. "FDX1 Can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma." Frontiers in Pharmacology, vol. 12, 2021, p. 749134, https://doi.org/10.3389/fphar.2021.749134.